𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Glial cell line-derived neurotrophic factor attenuates the excitotoxin-induced behavioral and neurochemical deficits in a rodent model of Huntington's disease

✍ Scribed by Dalia M Araujo; Dana C Hilt


Book ID
117491850
Publisher
Elsevier Science
Year
1997
Tongue
English
Weight
198 KB
Volume
81
Category
Article
ISSN
0306-4522

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Reversible neurochemical changes mediate
✍ Xin Yang; Birgit Mertens; Enni Lehtonen; Linda Vercammen; Olivier Bockstael; Abd 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 593 KB

## Abstract ## Background Efficient protection of dopaminergic neurons against a subsequent 6‐hydroxydopamine lesion by glial cell line‐derived neurotrophic factor (GDNF) gene delivery has been demonstrated. By contrast, the neurorestorative effects of GDNF administered several weeks after the tox

Glial cell line-derived neurotrophic fac
✍ Aleksandra Glavaski-Joksimovic; Tamas Virag; Thomas A. Mangatu; Michael McGrogan 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 456 KB 👁 1 views

## Abstract Parkinson's disease (PD) is a neurodegenerative disease characterized by progressive degeneration of nigrostriatal dopaminergic (DA) neurons. The therapeutic potential of glial cell line‐derived neurotrophic factor (GDNF), the most potent neurotrophic factor for DA neurons, has been dem

Activation of the extracellular signal-r
✍ Niklas Lindgren; Rehana K. Leak; Kirsten M. Carlson; Amanda D. Smith; Michael J. 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 851 KB

## Abstract Glial cell line‐derived neurotrophic factor (GDNF) has been shown to be neuroprotective in animal models of the dopamine deficiency in Parkinson's disease. To examine the role of the extracellular signal‐regulated kinases 1 and 2 (ERK1/2) in this process, we infused a single dose of GDN